One Of A Kind Company

[stonehorse]

Another one of a kind is Organovo. they came public last year, under $2 quickly went to $10 and just as quickly went back to under $2 but has been back to $6 and in between since. This is the typical start up bio research company in that revenues are not much, just over $1mil in 2012 but they have enough cash to last through 2013 and still have some warrants to fall back on before they have to raise more by other dilutive means Here is what they do and what makes them one of a kind.

Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


12/18/2012
Organovo Partners With Autodesk Research to Develop 3D Bioprinting Software

01/30/2013
Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research

Feb 20, 2013 Organovo Partners With ZenBio to Create 3D Tissue Models